1st Quarter Results

IQE PLC 23 May 2000 IQE plc 1st Quarter 2000 Results : Record Sales and Increased Profits IQE plc (IQE), the world's largest 'pure play' outsource supplier of customised epitaxial wafers to the compound semiconductor industry, is pleased to announce its 1st Quarter results for the period ended 31 March 2000. Highlights * Record Q1 sales, up 40% to £6.351m (Q1/1999: £4.535m) and up 25.3% sequentially on Q4 1999 (£5.068m), despite continued capacity limitations. * Net profit before tax and exceptional costs for Q1 up 70% to £0.373m (Q1 1999 : £0.220m). * EPS for Q1 up to 1.98p per share, up by 42% (Q1 1999: 1.41 pence per share). * Continued strong demand for the Company's products. * First of new generation MBE systems at Bethlehem now in full production of 6' epiwafers. * High quality HBT technology for both AlGaAs and GaInP products established on new generation MOCVD systems in Cardiff and now under customer qualification. * Strong acceleration in capital expenditure programme to maximise opportunities. * In addition, since the end of Q1, IQE completed a successful secondary offering and listing on LSE to raise £37m (US $56m) for expansion of business. Dr Drew Nelson, Chairman & CEO commented: 'The Groups results are now beginning to show the fruits of our investments from the IPO as our new capacity starts to come on line, resulting in record revenues for the first quarter of 2000. We are continuing to increase our profitability despite significantly increased investment to further accelerate our capacity expansion plans in order to cope with growing customer demand for our products. Our successful secondary offering and listing on the LSE, which we completed last week, will not only provide the funds for rapid expansion of our capacity but will also enable greater visibility for the Group and increased liquidity in our shares. We continue to look forward to the future with great confidence.' For further information please contact: Drew Nelson, Chairman & CEO, IQE (029)20 839400 Tom Hierl, Chief Technical Officer, IQE (+1) 610 861 6930 Tim Thompson/Nicola Cronk, Buchanan Communications 020 7466 5000 1st Quarter 2000 Results Introduction The Groups products continue to be in very strong demand, driven by the increasing need to expand the Internet infrastructure via higher capacity and faster optical fibre data links and to provide increasingly sophisticated mobile communications systems. In addition, many other applications of compound semiconductor devices continue to grow rapidly. As previously indicated, we are accelerating our capacity expansion programme to cope with the increasing demand for epitaxial wafers and our successful secondary offering will allow us to establish a much greater capacity for manufacturing wafers in a highly cost effective manner over the coming twelve months. Important milestones achieved during the quarter included establishing full production of 6' wafers on the first of the new generation multiwafer 6' MBE equipment in Bethlehem, and successfully developing a high quality HBT production technology for both AlGaAs and GaInP products on the new AIX 2600 multiwafer MOCVD reactors in Cardiff. These products are now in qualification with a significant number of customers around the world. Results for Q1 2000. Q1 sales reached their highest ever quarterly level of £6.351m, an increase of 40% over Q1-1999 (£4.535m) and up sequentially by 25.3% on Q4-1999 revenues (£5.068m). Turnover continued to be limited by testing and qualification, but benefited significantly from the increased revenue generated from our new multiwafer MBE (VG150) system which we were able to establish in full production of 6' wafers, which is fully qualified by our customers - the first in the industry. As previously indicated gross margin was impacted by continued testing and qualification and by increased investment costs associated with building our infrastructure and staffing ahead of further acceleration of our expansion plans. Nonetheless gross profit increased 29% to £2.039m compared with Q1-1999 (£1.576m), although gross margin was reduced to 32.1% from 34.8% for the same period last year. SG&A costs were reduced as a percentage of revenue to 16.8% from 18.8% for Q1-2000 compared with Q1-1999. Increased R&D costs associated with the successful HBT product development limited the pre-exceptional operating profit increase to £0.423m, still up by 12% from Q1-1999 (£0.378m). Net profits before taxes and exceptional costs rose to £0.373m, an increase of 70% compared with the same period last year (Q1-1999:£0.220m). Pre- exceptional post tax profits increased to £0.269m (Q1- 1999:£0.190m) resulting in earnings of 1.98 pence per share for the quarter compared with 1.41 pence for the same quarter in 1999. Including exceptionals, post tax profits increased by 77% to £0.230m from £0.130m in Q1- 1999. Overview The 1st quarter of 2000 saw several more major milestones achieved and continued strong demand for our products, particularly those used in optical fibre communication systems which provide increased capacity for Internet infrastructure systems and those used to support rapidly increasing growth in the mobile telephony marketplace. We successfully established in full production our new multiwafer 6' MBE system (VG150) in Bethlehem with our three largest electronics customers, enabling us to substantially increase our Q1 revenues. As this is the first of a new generation of large capacity MBE systems, the risk associated with its operation has now been eliminated and we have established a commanding time lead over our competitors. We have several further large capacity MBE systems arriving over the next four months, to cope with customer demand and additional design improvements based on our experiences to date are being incorporated into the new systems, which will include full automation. We have also been successful in establishing a powerful HBT technology for both the AlGaAs and GaInP products on the new generation AIX2600 MOCVD platform in Cardiff, and device results achieved to date are highly encouraging. These products for the mobile telephony and optical fibre communication systems are currently in qualification with a significant number of customers around the world. We will receive several more of these large capacity MOCVD systems over the next twelve months which will be used for a variety of products, including Vertical Cavity Surface Emitting Lasers (VCSELs) for which there is a rapidly growing market in local area optical fibre networks. IQE is currently the leading provider of these complex wafers to the industry. The development of our large scale multiwafer 4' and 6' technology for both HBT and PHEMT is particularly relevant since the electronics part of the Compound Semiconductor Industry is moving rapidly to 6' wafer processing, with some customers now in production with 6' wafer technology. Almost all of the major companies in the sector have now announced their plans to move to 6' wafers, confirming the timeliness of our strategy to invest heavily in large scale 6' epitaxy equipment, which we announced last September. Capital expenditure, including deposits on new equipment in the quarter was £4.154m, ahead of our original intentions and reflecting the significant acceleration in our capex plans which are aimed at bringing forward our capacity increase to cope with rising customer demands. Trading Prospects The markets for our products are continuing to grow rapidly, with demand especially strong in the materials for Internet infrastructure projects such as Dense Wavelength Division Multiplexing (DWDM) optical fibre systems for long haul and metro networks, short haul optical fibre links and mobile telephony systems. Almost all the major companies in the electronics sector have announced plans to move to 6' wafer processing, as anticipated by IQE last September, strongly supporting the rapid growth strategy adopted by the Group. In addition the installation at IQE's sites of the new generation reactors, which are also much more cost effective at producing 4' wafers compared to existing technology, has presented the Group with the opportunity to supply traditionally fully captive manufacturing facilities with a more cost effective alternative than fully re-equipping their plants with new generation reactors. This will encourage current 'captive' manufacturers to reappraise their in-house strategy, faced with the prospect of having to replace a significant amount of their current manufacturing equipment. As a result of this acceleration in our plans, we announced a primary fund raising of £37m (US $56m) and a move to the techMARK index of the LSE. This was highly successful, with the share subscription being four times oversubscribed in a very difficult and volatile market. The funds raised for the Group will be used to execute our ambitious expansion plan, which will give IQE a significant advantage over its competitors in providing a comprehensive and cost effective epitaxial wafer foundry service to the worldwide compound semiconductor industry. Overall, the rapidly growing demand and ever increasing range and size of applications for compound semiconductor wafers, represents a unique opportunity for IQE to establish itself as the first choice supplier globally for outsource epi-wafer supply, particularly as we have the financial strength to execute our plans. We expect our revenues will grow strongly as new reactors capacity is brought on line during the next twelve months, and we continue to look forward to the future with great confidence. Profit and Loss Account Quarter 1 Quarter 1 Quarter 1 31 Mar 00 31 Mar 00 31 Mar 99 unaudited excluding (All figures unaudited exceptionals unaudited GBP000s except Earnings/Share) Sales 6,351 6,351 4,535 Cost of Sales (4,312) (4,312) (2,959) Gross Profit 2,039 2,039 1,576 Gross Margin % 32.1 32.1 34.8 Research/Development (545) (545) (345) Selling/General/Admin (1,070) (1,070) (853) Selling/General/Admin (39) 0 (60) Exceptionals Operating Profit 384 423 318 Operating Marging % 6.1 6.7 7.0 Interest Receivable/(Payable) (50) (50) (158) Interest (Payable) Exceptional (0) 0 0 Net Profit before Taxes 334 373 160 Net Margin % 5.3 5.9 3.5 Current Taxes (104) (104) (30) Deferred taxes (0) (0) (0) Dividend (0) (0) (0) Profit/(Loss) after Taxes 230 269 130 Earnings £/share 0.02 0.02 0.01 Earnings $/share 0.03 0.03 0.02 Exchange Rate $/£ Average 1.63 1.63 1.62 Exchange RAte $/£ Closing 1.61 1.61 1.61 Quarter 1 12 months 31 Mar 1999 31 Dec 1999 Unaudited excluding exceptionals audited Sales 4,535 19,043 Cost of Sales (2,959) (12,558) Gross Profit 1,576 6,485 Gross Margin % 34.8 34.1 Research/Development (345) (1,302) Selling/General/Admin (853) (3,729) Selling/General/Admin Exceptionals 0 (171) Operating Profit 378 1,283 Operating Marging % 8.3 6.7 Interest Receivable/(Payable) (158) (261) Interest (Payable) Exceptional (0) (328) Net Profit before Taxes 220 694 Net Margin % 4.9 3.6 Current Taxes (30) 47 Deferred taxes (0) 102 Dividend (0) 0 Profit/(Loss) after Taxes 190 843 Earnings £/share 0.02 0.06 Earnings $/share 0.03 0.10 Exchange Rate $/£ Average 1.62 1.61 Exchange Rate $/£ Closing 1.61 1.61 Balance Sheet As At As At As At 31 Mar 2000 31 Mar 1999 31 Dec 1999 (unaudited) (unaudited) audited Fixed Assets Tangible Fixed assets 14,759 7,094 11,483 Current Assets Stocks 3,058 1,533 2,573 Debtors 9,076 3,535 7,742 Cash and Bank 3,932 383 8,117 Total Current Assets 16,066 5,451 18,432 Creditors Falling (5,392) (6,268) (4,517) Due within One Year Net Current Asset 10,674 -817 13,915 Total Assets less Current Liablities 25,433 6,277 25,398 Creditors Falling Due after One Year Deferred Income (89) (8) (93) Long Term Borrowings (3,840) (5,029) (4,024) Deferred Tax Liability (331) (491) (331) Net Assets 21,176 749 20,950 Capital and Reserves Called Up Share Captal 1,366 1,040 1,360 Merger Reserve (605) (759) (605) Share Premium Account 18,916 0 18,907 Retained Earnings 1,551 568 1,281 Other Reserves (12) (100) 7 Total Equity Shareholders' Funds 21,176 749 20,950 CASH FLOW Quarter 1 Quarter 1 12 Months STATEMENT 31 Mar 2000 31 Mar 1999 31 December 1999 (All figures GBP000s) unaudited unaudited audited Net Inflow/(outflow) (96) 1,250 (2,877) from operations Returns on Investment and Servicing Finance Interest (50) (158) (589) Receivable/(Payable) Capital Expenditure (3,850) (1,917) (7,413) Equity Dividend Paid (0) (0) 0 Tax Paid (20) 5 (282) Net Inflow/(Outflow) (4,016) (820) (11,161) before financing Financing Issue of Ordinary Share Capital 6 0 319 Proceeds of IPO (net) 9 (0) 19,061 Loans (184) 361 (443) Net Inflow/(Outflow) from Financing (169) 361 18,937 Increase/(Decrease) in Cash and Bank (4,185) (458) 7,776 Overdrafts Quarter 1 Quarter 1 12 months 31 Mar 2000 31 Mar 1999 31 Dec 1999 UK GAAP unaudited unaudited audited RECONCILIATIONS TO IAS (All figures GBP000s) ---------------------------------------- (1) Statement of Cash Flows The following shows the statement of cash flows as if they had presented under IAS Cash Inflow/(Outflow) (129) 1,158 (3,525) from Opertions Cash Inflow/(Outflow) (3,850) (1,917) (7,136) from Investing Cash Inflow/(Outflow) Financing (208) 301 18,438 Net Increase/(Decrease) in Cash and cash (4,188) (458) 7,777 equivalents Cash and Cash Equivalent at the Start of the Period per IAS 8,118 341 341 Exchange difference 2 (0) 0 Cash and Cash Equivalents at the end of the period IAS per IAS 3,933 (117) 8,118 2) Goodwill Goodwill of £284,000 arose on acquisition of Epitaxial Products by EPIH on 27 March 1996. Under UK GAAP, this has been written off directly to reserves. Under IAS, however, goodwill arising on acquisition should be recognised as an asset and amortised over its useful life. The following shows the retained profit and total net assets as if they had been prepared under IAS with goodwill amortized over 5 years. Profit/(Loss) after Taxes and Exceptional Items 230 130 1,342 Dividends (0) (0) 0 Retained Profit/(Loss) per UK GAAP 230 130 1,342 Goodwill Amortisation (14) (14) (57) Retained Profit/(Loss) per IAS 216 116 1,285 Equity Shareholders' Funds per UK GAAP 21,176 749 20,950 Goodwill Capitalisation at Cost 284 284 284 Accumulated Goodwill Amortisation (227) (170) (213) Equity Shareholders' Funds per IAS 21,232 863 21,021

Companies

IQE (IQE)
UK 100

Latest directors dealings